Skip to main content
. 2010 Jul 17;150(1):202–206. doi: 10.1016/j.jbiotec.2010.07.019

Fig. 5.

Fig. 5

Blockade of TGEV infection by the pAPNs. TGE virons were treated with pAPN proteins at various concentrations and then the viruses were used to infect ST cells. A control protein (IBV S1) produced in the same system as pAPN was used as control to treat viruses. The protein concentration is shown in x-axis and the inhibition rate of the pAPNs determined by plaque assays is indicatd in y-axis. The 100% infectivity value corresponds to an average plaque number of approx. 200.